Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
BlackRock Resources & Commodities Strategy Trust
BCX
$988M
| $44.7M | ﹤0.01% |
3,951,148
+196,133
| +5% | +$2.36M |
|
2352
Goldman Sachs BDC
GSBD
$1.14B
| $44.7M | ﹤0.01% |
4,713,836
+1,083,863
| +30% | +$10.1M |
|
2353
Fortuna Silver Mines
FSM
$3.59B
| $44.7M | ﹤0.01% |
5,286,739
-973,014
| -16% | -$9.43M |
|
2354
Global X Russell 2000 Covered Call ETF
RYLD
$1.39B
| $44.7M | ﹤0.01% |
2,792,826
+188,526
| +7% | +$2.93M |
|
2355
First Trust Dorsey Wright International Focus 5 ETF
IFV
$236M
| $44.6M | ﹤0.01% |
1,655,802
+385,027
| +30% | +$10.5M |
|
|
AAMI
2356
Acadian Asset Management
AAMI
$3.4B
| $44.6M | ﹤0.01% |
623,422
+85,779
| +16% | +$5.98M |
|
2357
Nuveen Preferred & Income Opportunities Fund
JPC
$2.77B
| $44.6M | ﹤0.01% |
5,655,933
+213,041
| +4% | +$1.68M |
|
2358
Compañía de Minas Buenaventura
BVN
$8.9B
| $44.6M | ﹤0.01% |
1,521,595
+105,152
| +7% | +$3.57M |
|
2359
CleanSpark
CLSK
$2.97B
| $44.5M | ﹤0.01% |
3,061,702
-3,697,802
| -55% | -$52.2M |
|
2360
iShares North American Natural Resources ETF
IGE
$768M
| $44.5M | ﹤0.01% |
792,391
-318,878
| -29% | -$19.3M |
|
2361
MGE Energy Inc
MGEE
$2.95B
| $44.5M | ﹤0.01% |
545,468
+239,075
| +78% | +$18.5M |
|
2362
Sabra Healthcare REIT
SBRA
$5.28B
| $44.5M | ﹤0.01% |
2,279,604
+37,361
| +2% | +$741K |
|
2363
ProPetro Holding
PUMP
$1.34B
| $44.4M | ﹤0.01% |
3,097,319
-78,747
| -2% | -$1.22M |
|
2364
Spyre Therapeutics
SYRE
$7.98B
| $44.4M | ﹤0.01% |
499,963
+253,244
| +103% | +$18.5M |
|
2365
First Financial Bancorp
FFBC
$3.44B
| $44.4M | ﹤0.01% |
1,311,735
+72,565
| +6% | +$2.22M |
|
2366
Progyny
PGNY
$1.99B
| $44.3M | ﹤0.01% |
1,535,897
-751,720
| -33% | -$16.8M |
|
2367
Ultragenyx Pharmaceutical
RARE
$2.53B
| $44.2M | ﹤0.01% |
1,324,805
-175,723
| -12% | -$4.36M |
|
2368
Cohen & Steers Duration Preferred & Income Fund
LDP
$600M
| $44.2M | ﹤0.01% |
2,089,803
+48,867
| +2% | +$1.01M |
|
2369
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$821M
| $44.2M | ﹤0.01% |
1,332,257
+654,849
| +97% | +$20.4M |
|
2370
X4 Pharmaceuticals
XFOR
$401M
| $44.2M | ﹤0.01% |
9,461,279
-5,713
| -0.1% | -$23.4K |
|
2371
iShares Convertible Bond ETF
ICVT
$7.63B
| $44.1M | ﹤0.01% |
362,461
+28,391
| +8% | +$3.29M |
|
2372
AXT Inc
AXTI
$3.87B
| $44.1M | ﹤0.01% |
611,974
-831,660
| -58% | -$74.9M |
|
2373
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.9B
| $44.1M | ﹤0.01% |
443,633
-26,308
| -6% | -$2.61M |
|
2374
Galicia Financial Group
GGAL
$6.73B
| $44.1M | ﹤0.01% |
880,638
-520,730
| -37% | -$24.5M |
|
2375
Hess Midstream
HESM
$5.09B
| $43.9M | ﹤0.01% |
1,167,570
-553,321
| -32% | -$21.3M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.